Q3 2019 13F Holders as of 9/30/2019
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
89.4M
-
Number of holders
-
22
-
Total 13F shares, excl. options
-
13.1M
-
Shares change
-
-11.4K
-
Total reported value, excl. options
-
$240M
-
Value change
-
-$2.84M
-
Number of buys
-
4
-
Number of sells
-
-8
-
Price
-
$18.65
Significant Holders of Milestone Pharmaceuticals Inc. - Common Shares (MIST) as of Q3 2019
26 filings reported holding MIST - Milestone Pharmaceuticals Inc. - Common Shares as of Q3 2019.
Milestone Pharmaceuticals Inc. - Common Shares (MIST) has 22 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13.1M shares
of 89.4M outstanding shares and own 14.62% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (3.52M shares), Novo Holdings A/S (2.67M shares), VHCP Management III, LLC (2.07M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.3M shares), BOXER CAPITAL, LLC (1.1M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (500K shares), ACUTA CAPITAL PARTNERS, LLC (370K shares), Invesco Ltd. (325K shares), BAKER BROS. ADVISORS LP (267K shares), and FMR LLC (240K shares).
This table shows the top 22 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.